Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer

BACKGROUND: Mutational analysis of the KRAS gene has recently been established as a complementary in vitro diagnostic tool for the identification of patients with colorectal cancer who will not benefit from anti-epidermal growth factor receptor (EGFR) therapies. Assessment of the mutation status of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sánchez-Muñoz, Alfonso, Gallego, Elena, de Luque, Vanessa, Pérez-Rivas, Luís G, Vicioso, Luís, Ribelles, Nuria, Lozano, José, Alba, Emilio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2010
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868051/
https://ncbi.nlm.nih.gov/pubmed/20385028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-136
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items